- A Case of Combination Therapy with Finasteride and Low Dose Dutasteride in the Treatment of Androgenetic Alopecia
-
Lee SY, Chun SW, Kim JB, Ro BI
- KMID: 2371094
- Korean J Dermatol.
- 2017 Feb;55(2):147-148.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Positive Role of Dutasteride in the Treatment of Localized Prostate Cancer
-
Kim JH
- KMID: 2307830
- Korean J Urol Oncol.
- 2015 Apr;13(1):24-28.
- doi: 10.0000/kjuo.2015.13.1.24
Dual inhibition of both 5AR1 and 5AR2 by dutasteride provides greater and more consistent inhibition of the conversion of testosterone to dihydrotestosterone (DHT) than selective inhibition of 5AR2 alone. Beyond... -
- CITED
-
- Close
- SHARE
-
- Close
- The Different Reduction Rate of Prostate-Specific Antigen in Dutasteride and Finasteride
-
Choi YH, Cho SY, Cho IR
- KMID: 2314614
- Korean J Urol.
- 2010 Oct;51(10):704-708.
PURPOSE: To compare and analyze the therapeutic effects and changes in the prostate-specific antigen (PSA) level with treatment with finasteride or dutasteride for benign prostatic hyperplasia (BPH) for 1 year. MATERIALS... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Dutasteride on Serum Prostate-specific Antigen (PSA) in Patients with Benign Prostate Hypertrophy
-
Lee GH, Hong JH, Kim HJ
- KMID: 2330634
- J Korean Continence Soc.
- 2008 Jun;12(1):42-47.
PURPOSE: 5alpha reductase, dutasteride, has widely used to treat enlarged prostate (BPH). By suppressing the conversion of testosterone to dihydrotestosterone it decreases serum prostate-specific antigen (PSA) which is very important... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Significance of Transrectal Ultrasonography and Efficacy of Dutasteride Treatment in Patients with Hemospermia
-
Kim YJ, Hwang EC, Kim SO, Jung SI, Kang TW, Kwon DD, Park K, Ryu SB
- KMID: 2226453
- Korean J Androl.
- 2011 Dec;29(3):206-212.
- doi: 10.5534/kja.2011.29.3.206
PURPOSE: The aims of this study were to investigate the clinical significance of transrectal ultrasonography (TRUS) and the efficacy of dutasteride (5alpha-reductase inhibitor) in patients with hemospermia. MATERIALS AND METHODS: From... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Two Weeks of Treatment with Dutasteride on Bleeding after Transurethral Resection of the Prostate
-
Kim KS, Jeong WS, Park SY, Kim YT, Moon HS
- KMID: 2320735
- World J Mens Health.
- 2015 Apr;33(1):14-19.
- doi: 10.5534/wjmh.2015.33.1.14
PURPOSE: Dutasteride affects the prostate by reducing intraprostatic dihydrotestosterone and prostate tissue vascularity. We evaluated the effect of pretreatment with dutasteride for two weeks on perioperative and postoperative bleeding during... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Medication with Dutasteride on Detection of Prostate Cancer in Patients with Serum Prostate-specific Antigen Level of 4~10 ng/ml
-
Shin JS, Cho SR
- KMID: 2298767
- Korean J Androl.
- 2008 Apr;26(1):29-34.
Purpose: We assessed the effects of medication with dutasteride on serum prostate-specific antigen (PSA), PSA density (PSAD) and prostate volume to avoid unnecessary biopsies. Materials and Methods: Between 2005 and 2007... -
- CITED
-
- Close
- SHARE
-
- Close
- Significance of intraprostatic architecture and regrowth velocity for considering discontinuation of dutasteride after combination therapy with an alpha blocker: A prospective, pilot study
-
Shindo T, Hashimoto , Shimizu T, Itoh N, Masumori N
- KMID: 2155306
- Korean J Urol.
- 2015 Apr;56(4):305-309.
- doi: 10.4111/kju.2015.56.4.305
PURPOSE: We conducted a prospective single-center study to evaluate the possibility of discontinuation of dutasteride after combination therapy with an alpha blocker for benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: We... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Short Term Dutasteride Therapy on Microvessel Density in Benign Prostatic Hyperplasia
-
Woo JH, Kang JY, Kim EK, Yoo TK
- KMID: 2311982
- Korean J Urol.
- 2008 Jun;49(6):515-519.
PURPOSE: Several studies have shown that finasteride limits hematuria in patients with benign prostatic hyperplasia(BPH). However, there are few reports addressing dutasteride therapy. We evaluated the effect of dutasteride on... -
- CITED
-
- Close
- SHARE
-
- Close
- Changes in Sexual Function in Benign Prostatic Hyperplasia Patients Taking Dutasteride: 1-Year Follow-Up Results
-
Chi BH, Kim SC
- KMID: 2315428
- Korean J Urol.
- 2011 Sep;52(9):632-636.
PURPOSE: Sexual adverse events (AEs), a major cause for discontinuing 5alpha-reductase inhibitor (5ARI) therapy for benign prostatic hyperplasia (BPH), are known to occur most frequently early in therapy and appear... -
- CITED
-
- Close
- SHARE
-
- Close
- Post-marketing Surveillance of the Safety of Dutasteride Prescribed to Korean Patients with Benign Prostate Hyperplasia
-
Kim JH, Bae JY, Oh SY, Lee YS
- KMID: 2334523
- J Korean Soc Clin Pharmacol Ther.
- 2012 Jun;20(1):85-94.
BACKGROUND: Dutasteride is an inhibitor of both types I and II 5 alpha-reductase and was approved in Korea in April 2004. This post-marketing surveillance was to assess the safety of... -
- CITED
-
- Close
- SHARE
-
- Close
- Retrospective Pharmacotherapeutic Evaluation of Dutasteride not Approved by US FDA for Androgenetic Alopecia in Korea
-
Cheon YJ, Kim JT, Lim SC
- KMID: 2226409
- Korean J Clin Pharm.
- 2015 Sep;25(3):171-177.
- doi: 10.0000/kjcp.2015.25.3.171
BACKGROUND: Androgenetic alopecia (AGA), one of alopecias, requires continuous treatment in order to prevent or stop it, and patient's compliance is very important. Currently, only two drugs (finasteride, minoxidil) have... -
- CITED
-
- Close
- SHARE
-
- Close
- Early dutasteride monotherapy in men with detectable serum prostate-specific antigen levels following radical prostatectomy: A prospective trial
-
Shin YS, Lee JW, Kim MK, Jeong YB, Park SC
- KMID: 2368474
- Investig Clin Urol.
- 2017 Mar;58(2):98-102.
- doi: 10.4111/icu.2017.58.2.98
PURPOSE: To investigate the effects of early administration of dutasteride in patients with detectable serum prostate-specific antigen (PSA) levels after radical prostatectomy (RP). MATERIALS AND METHODS: A prospective open-label study, with... -
- CITED
-
- Close
- SHARE
-
- Close
- Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment
-
Sung HH, Yu J, Kang SJ, Chae MR, So I, Park JK, Lee SW
- KMID: 2443240
- World J Mens Health.
- 2019 May;37(2):240-248.
- doi: 10.5534/wjmh.180082
PURPOSE: The current study is aimed to assess whether a longer duration of 5α-reductase inhibitor (5α-RI) exposure was associated with higher rate of permanent erectile dysfunction (ED) in a rat... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor
-
Choi H, Chang YS, Park BH, Ko DH, Moon YJ, Kim JB
- KMID: 2298808
- Korean J Androl.
- 2012 Apr;30(1):45-51.
- doi: 10.5534/kja.2012.30.1.45
PURPOSE: To compare the clinical therapeutic efficacy of finasteride and dutasteride as 5-alpha reductase inhibitor (5-ARI) in the medical treatment of benign prostate hyperplasia. MATERIALS AND METHODS: From July 2007 to... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia
-
Choi GS, Kim JH, Oh SY, Park JM, Hong JS, Lee YS, Lee WS
- KMID: 2344814
- Ann Dermatol.
- 2016 Aug;28(4):444-450.
- doi: 10.5021/ad.2016.28.4.444
BACKGROUND: After the approval of dutastride for androgenic alopecia (AGA) in 2009, Korean authority required a post-marketing surveillance to obtain further data on its safety profile. OBJECTIVE: The objective was to... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride Treatment in Korean Men with Benign Prostatic Hypertrophy
-
Park SW, Kim CS, Lee G
- KMID: 2314582
- Korean J Urol.
- 2010 Dec;51(12):824-830.
PURPOSE: Studies of genetic variation in the prostate-specific antigen (PSA) gene have improved the diagnostic accuracy of PSA for diagnosing prostate diseases in Caucasians. However, the reference ranges and pharmacokinetics... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Status of 5alpha-Reductase Inhibitors in Prostate Disease Management
-
Kang DI, Chung JI
- KMID: 2316025
- Korean J Urol.
- 2013 Apr;54(4):213-219.
The key enzyme in the androgen synthesis and androgen receptor pathways is 5alpha-reductase (5-AR), which occurs as three isoenzymes. Types I and II 5-ARs the most important clinically, and two... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of Treatment With Statins on Prostate-Specific Antigen and Prostate Volume in Patients With Benign Prostatic Hyperplasia
-
Lee SH, Park TJ, Bae MH, Choi SH, Cho YS, Joo KJ, Kwon CH, Park HJ
- KMID: 2315955
- Korean J Urol.
- 2013 Nov;54(11):750-755.
PURPOSE: We investigated the impact on prostate-specific antigen (PSA) and prostate volume (PV) of statin medication for 1 year in patients with benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: We retrospectively... -
- CITED
-
- Close
- SHARE
-
- Close
- Hair characteristics and androgenetic alopecia in Koreans
-
Choi GS
- KMID: 2192900
- J Korean Med Assoc.
- 2013 Jan;56(1):45-54.
- doi: 10.5124/jkma.2013.56.1.45
The scalp hair is composed of one hundred thousand of hairs. Each hair goes through the three phases of the hair cycle, which causes the hair to turn from an... -
- CITED
-
- Close
- SHARE
-
- Close
